- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04674033
The Sweet PEA Study: Effects of Diet During Pregnancy on Infant Growth and Development.
December 3, 2024 updated by: Michael I. Goran, University of Southern California
The Sweet PEA Study: a Pilot Study of the Impact of Non-nutritive Sweetener Consumption During Pregnancy on Maternal and Infant Metabolic Health
The purpose of the Sweet PEA Study is to determine whether diet during pregnancy has an effect on infant's growth, body composition, and brain development.
Study Overview
Status
Completed
Conditions
Detailed Description
Rationale: Non-nutritive sweetener (NNS) consumption during pregnancy is prevalent, but effects on maternal and infant health are not well known.
Intervention: None Objectives: To determine whether NNS consumption during pregnancy is associated with increased infant body fat, as well as differences in infant growth, brain structure/function, gut microbiota, and gestational diabetes.
Study population: Women prior to 28 weeks' gestation, determined to have either low/no NNS consumption (control) or high NNS consumption (experimental), based on a pre-screening survey.
Methodology: Identify two groups (low/high consumers) in early pregnancy, collect data during pregnancy remotely (telephone, internet, medical records) to determine diet and any link to pregnancy complications, have in-person visits with mothers/infants at 1, 6, and 12 months of age, collecting: body composition data (by EchoMRI), brain structure/connectivity (MRI), stool samples.
Outcomes: Primary outcome is infant adiposity at 1, 6, and 12 months.
Additional measures include infant growth, feeding behaviors, brain structure/ connectivity, gut microbiota, and maternal metabolic outcomes during routine gestational testing (fasting glucose, insulin, triglycerides, gestational diabetes diagnosis) Follow-up: This will operate as a small pilot study, and a larger study with more participants, a wider spectrum of NNS exposure, and longer follow up (into childhood and beyond) may follow.
Statistics: Multivariate linear mixed effects examining maternal NNS intake and outcomes across time (repeated measures)
Study Type
Observational
Enrollment (Actual)
93
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Los Angeles, California, United States, 90027
- Children's Hospital Los Angeles
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Sampling Method
Probability Sample
Study Population
Pregnant women (18 - 40 years) who do and do not report non-nutritive sweetener consumption, and their infants (<1-12 months) from Los Angeles, CA.
Description
Inclusion Criteria:
Mothers:
- Pregnant women prior to 28 weeks gestation
- Report the least NNS consumption of pre-screened participants (0 servings per week - representing the control group) and most NNS consumption of pre-screened participants (≥ 5 servings per week - representing the experimental group).
- 18-40 years of age
- Singleton pregnancy
- Be able/willing to understand the procedures of the study
- Be able to read English at a 5th grade level (materials also available in Spanish, if required)
Infants:
- Infant's mother must be enrolled in the study and provide infant assent to participate
Exclusion Criteria:
Mothers:
- Physician diagnosis of a major medical illness
- Pre-existing diabetes (type 1 or type 2), or GDM in a previous pregnancy
- Physical, mental, or cognitive issues preventing participation
- Medications that may affect body weight, body composition, insulin resistance, or lipid profiles
- Tobacco or drug use (any current use or quitting during pregnancy)
- Alcohol consumption during pregnancy (>1 drink per week)
Infants:
- Presumed or known congenital birth defects
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Consumer
Participants who self-report regular consumption of non-nutritive sweeteners (>/=5 servings/week) based on a pre-screening dietary survey.
|
|
Non-Consumer
Participants who self-report no consumption of non-nutritive sweeteners (0 servings/week) based on a pre-screening dietary survey.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Infant body fat measured using an EchoMRI body composition analyzer at 6 months
Time Frame: 6 months
|
An EchoMRI infant body composition analyzer (EchoMRI LLC., Houston TX) will be used to measure infant body fat in grams.
|
6 months
|
|
Infant body fat measured using an EchoMRI body composition analyzer at 12 months
Time Frame: 12 months
|
An EchoMRI infant body composition analyzer (EchoMRI LLC., Houston TX) will be used to measure infant body fat in grams.
|
12 months
|
|
Infant lean mass measured using an EchoMRI body composition analyzer at 6 months
Time Frame: 6 months
|
An EchoMRI infant body composition analyzer (EchoMRI LLC., Houston TX) will be used to measure infant lean mass in grams.
|
6 months
|
|
Infant lean mass measured using an EchoMRI body composition analyzer at 12 months
Time Frame: 12 months
|
An EchoMRI infant body composition analyzer (EchoMRI LLC., Houston TX) will be used to measure infant lean mass in grams.
|
12 months
|
|
Infant free body water measured using an EchoMRI body composition analyzer at 6 months
Time Frame: 6 months
|
An EchoMRI infant body composition analyzer (EchoMRI LLC., Houston TX) will be used to measure infant free body water in grams.
|
6 months
|
|
Infant free body water measured using an EchoMRI body composition analyzer at 12 months
Time Frame: 12 months
|
An EchoMRI infant body composition analyzer (EchoMRI LLC., Houston TX) will be used to measure infant free body water in grams.
|
12 months
|
|
Infant length at 1 Month
Time Frame: 1 month
|
Infant length (cm) will be measured using an infant measure mat.
|
1 month
|
|
Infant length at 6 Months
Time Frame: 6 months
|
Infant length (cm) will be measured using an infant measure mat.
|
6 months
|
|
Infant length at 12 Months
Time Frame: 12 months
|
Infant length (cm) will be measured using an infant measure mat.
|
12 months
|
|
Infant weight at 1 Month
Time Frame: 1 month
|
Infant weight (kg) will measured using a portable digital scale.
For infants that need to be held, weight will be calculated as follows: (combined mother + infant weight) - (mother only weight).
|
1 month
|
|
Infant weight at 6 Months
Time Frame: 6 months
|
Infant weight (kg) will measured using a portable digital scale.
For infants that need to be held, weight will be calculated as follows: (combined mother + infant weight) - (mother only weight).
|
6 months
|
|
Infant weight at 12 Months
Time Frame: 12 months
|
Infant weight (kg) will measured using a portable digital scale.
For infants that need to be held, weight will be calculated as follows: (combined mother + infant weight) - (mother only weight).
|
12 months
|
|
Infant weight z-scores at 1 Month
Time Frame: 1 month
|
Weight and length will be used to calculate weight-for-length (WLZ) and weight-for-age (WAZ) z-scores using the WHO Child Growth Standards, as recommended by the CDC for children <24 mos.
|
1 month
|
|
Infant weight z-scores at 6 Months
Time Frame: 6 months
|
Weight and length will be used to calculate weight-for-length (WLZ) and weight-for-age (WAZ) z-scores using the WHO Child Growth Standards, as recommended by the CDC for children <24 mos.
|
6 months
|
|
Infant weight z-scores at 12 Months
Time Frame: 12 months
|
Weight and length will be used to calculate weight-for-length (WLZ) and weight-for-age (WAZ) z-scores using the WHO Child Growth Standards, as recommended by the CDC for children <24 mos.
|
12 months
|
|
Infant body fat measured using an EchoMRI body composition analyzer at 1 month
Time Frame: 1 month
|
An EchoMRI infant body composition analyzer (EchoMRI LLC., Houston TX) will be used to measure infant body fat in grams.
|
1 month
|
|
Infant lean mass measured using an EchoMRI body composition analyzer at 1 month
Time Frame: 1 month
|
An EchoMRI infant body composition analyzer (EchoMRI LLC., Houston TX) will be used to measure infant lean mass in grams.
|
1 month
|
|
Infant total body water measured using an EchoMRI body composition analyzer at 1 month
Time Frame: 1 month
|
An EchoMRI infant body composition analyzer (EchoMRI LLC., Houston TX) will be used to measure infant total body water in grams.
|
1 month
|
|
Infant total body water measured using an EchoMRI body composition analyzer at 6 months
Time Frame: 6 month
|
An EchoMRI infant body composition analyzer (EchoMRI LLC., Houston TX) will be used to measure infant total body water in grams.
|
6 month
|
|
Infant total body water measured using an EchoMRI body composition analyzer at 12 months
Time Frame: 12 month
|
An EchoMRI infant body composition analyzer (EchoMRI LLC., Houston TX) will be used to measure infant total body water in grams.
|
12 month
|
|
Infant free body water measured using an EchoMRI body composition analyzer at 1 month
Time Frame: 1 month
|
An EchoMRI infant body composition analyzer (EchoMRI LLC., Houston TX) will be used to measure infant free body water in grams.
|
1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Maternal height at 6 months
Time Frame: 6 months
|
Height (cm) will be measured using a stadiometer.
|
6 months
|
|
Maternal height at 12 months
Time Frame: 12 months
|
Height (cm) will be measured using a stadiometer.
|
12 months
|
|
Maternal weight at 6 months
Time Frame: 6 months
|
Weight (kg) will be measured using a portable digital scale.
|
6 months
|
|
Maternal weight at 12 months
Time Frame: 12 months
|
Weight (kg) will be measured using a portable digital scale.
|
12 months
|
|
Maternal resting heart rate at 6 months
Time Frame: 6 months
|
Sitting heart rate will be measured on the right arm after the subject has rested quietly for 5 minutes using a digital blood pressure monitor (Omron 3-series).
|
6 months
|
|
Maternal resting heart rate at 12 months
Time Frame: 12 months
|
Sitting heart rate will be measured on the right arm after the subject has rested quietly for 5 minutes using a digital blood pressure monitor (Omron 3-series).
|
12 months
|
|
Infant feeding score assessed by Infant Feeding Questionnaire at 6 months
Time Frame: 6 months
|
Infant feeding score will be assessed using the Baughcum Infant Feeding Questionnaire.
Questions are scored using the following scale: 1-5; never, rarely, sometimes, often, always.
Average scores will be used to determine the following constructs: concern about the child undereating or becoming underweight; concern about infant's hunger; awareness of infant's cues; concern about the infant becoming overweight or overeating; feeding the infant on schedule; using food to calm the infant; social interaction during feeding.
|
6 months
|
|
Infant feeding score assessed by Infant Feeding Questionnaire at 12 months
Time Frame: 12 months
|
Infant feeding score will be assessed using the Baughcum Infant Feeding Questionnaire.
Questions are scored using the following scale: 1-5; never, rarely, sometimes, often, always.
Average scores will be used to determine the following constructs: concern about the child undereating or becoming underweight; concern about infant's hunger; awareness of infant's cues; concern about the infant becoming overweight or overeating; feeding the infant on schedule; using food to calm the infant; social interaction during feeding.
|
12 months
|
|
Infant feeding style score assessed by Infant Feeding Style Questionnaire at 6 months
Time Frame: 6 months
|
Infant feeding style score will be assessed using the Thompson Infant Feeding Style Questionnaire.
Questions are scored using the following scale: 1-5; disagree, slightly disagree, neutral, slightly agree, agree.
Average scores will be used to determine the following constructs: laissez-faire; pressuring; restrictive; responsive; and indulgent.
|
6 months
|
|
Infant feeding style score assessed by Infant Feeding Style Questionnaire at 12 months
Time Frame: 12 months
|
Infant feeding style score will be assessed using the Thompson Infant Feeding Style Questionnaire.
Questions are scored using the following scale: 1-5; disagree, slightly disagree, neutral, slightly agree, agree.
Average scores will be used to determine the following constructs: laissez-faire; pressuring; restrictive; responsive; and indulgent.
|
12 months
|
|
Infant behavior score assessed by Infant Behavior Questionnaire at 6 months
Time Frame: 6 months
|
Infant behavior score will be assessed using the Rothbart Infant Behavior Questionnaire.
Questions are scored using the following scale: 1-7; never, very rarely, less than half the time, about half the time, more than half the time, almost always, always.
Composite scores will be used to determine the following constructs: surgency/extroversion; negative affectivity; and orienting/regulation.
|
6 months
|
|
Infant behavior score assessed by Infant Behavior Questionnaire at 12 months
Time Frame: 12 months
|
Infant behavior score will be assessed using the Rothbart Infant Behavior Questionnaire.
Questions are scored using the following scale: 1-7; never, very rarely, less than half the time, about half the time, more than half the time, almost always, always.
Composite scores will be used to determine the following constructs: surgency/extroversion; negative affectivity; and orienting/regulation.
|
12 months
|
|
Infant eating behavior score assessed by Baby Eating Behavior Questionnaire at 6 months
Time Frame: 6 months
|
Infant eating behavior score will be assessed using the Llewellyn Baby Eating Behavior Questionnaire.
Questions are scored using the following scale: 1-5; never, rarely, sometimes, often, always.
Average scores will be used to determine the following constructs: food responsiveness; satiety responsiveness; slowness in eating; enjoyment of food; and general appetite.
|
6 months
|
|
Infant eating behavior score assessed by Baby Eating Behavior Questionnaire at 12 months
Time Frame: 12 months
|
Infant eating behavior score will be assessed using the Llewellyn Baby Eating Behavior Questionnaire.
Questions are scored using the following scale: 1-5; never, rarely, sometimes, often, always.
Average scores will be used to determine the following constructs: food responsiveness; satiety responsiveness; slowness in eating; enjoyment of food; and general appetite.
|
12 months
|
|
Infant Magnetic Resonance Imaging (MRI) brain scan at 6 months
Time Frame: 6 months
|
Infant brain will be scanned using Magnetic Resonance Imaging (MRI) to measure structure and function.
|
6 months
|
|
Maternal gut microbiome at 6 months
Time Frame: 6 months
|
Stool samples will be collected in OmniGUT gene kits and aliquoted to be stored at -80oC.
Gut microbes will be analyzed using 16S sequencing.
|
6 months
|
|
Maternal gut microbiome at 12 months
Time Frame: 12 months
|
Stool samples will be collected in OmniGUT gene kits and aliquoted to be stored at -80oC.
Gut microbes will be analyzed using 16S sequencing.
|
12 months
|
|
Maternal height at 1 month
Time Frame: 1 month
|
Height (cm) will be measured using a stadiometer.
|
1 month
|
|
Maternal weight at 1 month
Time Frame: 1 month
|
Weight (kg) will be measured using a portable digital scale.
|
1 month
|
|
Maternal BMI at 1 Month
Time Frame: 1 month
|
Body Mass Index (BMI) will be calculated based on the equation (weight in kg)/(height in m)^2.
|
1 month
|
|
Maternal BMI at 6 Months
Time Frame: 6 months
|
Body Mass Index (BMI) will be calculated based on the equation (weight in kg)/(height in m)^2.
|
6 months
|
|
Maternal BMI at 12 Months
Time Frame: 12 months
|
Body Mass Index (BMI) will be calculated based on the equation (weight in kg)/(height in m)^2.
|
12 months
|
|
Maternal blood glucose at Pregnancy visit 2
Time Frame: ~35 weeks' gestation
|
Mothers will self-report their most recent blood glucose levels.
|
~35 weeks' gestation
|
|
Maternal pregravid BMI
Time Frame: 24-28 weeks' gestation
|
Maternal BMI prior to pregnancy will be derived from pregravid BMI (recall during pregnancy) using the equation (weight in kg)/(height in m)^2.
|
24-28 weeks' gestation
|
|
Maternal blood pressure at 1 month
Time Frame: 1 month
|
Sitting blood pressure will be measured on the right arm after the subject has rested quietly for 5 minutes using a digital blood pressure monitor (Omron 3-series).
|
1 month
|
|
Maternal blood pressure at 6 months
Time Frame: 6 months
|
Sitting blood pressure will be measured on the right arm after the subject has rested quietly for 5 minutes using a digital blood pressure monitor (Omron 3-series).
|
6 months
|
|
Maternal blood pressure at 12 months
Time Frame: 12 months
|
Sitting blood pressure will be measured on the right arm after the subject has rested quietly for 5 minutes using a digital blood pressure monitor (Omron 3-series).
|
12 months
|
|
Maternal resting heart rate at 1 month
Time Frame: 1 month
|
Sitting heart rate will be measured on the right arm after the subject has rested quietly for 5 minutes using a digital blood pressure monitor (Omron 3-series).
|
1 month
|
|
Maternal diet at Pregnancy visit 1
Time Frame: 24-28 weeks' gestation
|
24-hour diet recalls will be conducted for one week day and one weekend day.
Dietary intake will be collected and analyzed using the most current version of the Nutrition Data System for Research software (NDSR).
|
24-28 weeks' gestation
|
|
Maternal diet at Pregnancy visit 2
Time Frame: ~35 weeks' gestation
|
24-hour diet recalls will be conducted for one week day and one weekend day.
Dietary intake will be collected and analyzed using the most current version of the Nutrition Data System for Research software (NDSR).
|
~35 weeks' gestation
|
|
Maternal diet at 1 month
Time Frame: 1 month
|
24-hour diet recalls will be conducted for one week day and one weekend day.
Dietary intake will be collected and analyzed using the most current version of the Nutrition Data System for Research software (NDSR).
|
1 month
|
|
Maternal diet at 6 months
Time Frame: 6 months
|
24-hour diet recalls will be conducted for one week day and one weekend day.
Dietary intake will be collected and analyzed using the most current version of the Nutrition Data System for Research software (NDSR).
|
6 months
|
|
Maternal diet at 12 months
Time Frame: 12 months
|
24-hour diet recalls will be conducted for one week day and one weekend day.
Dietary intake will be collected and analyzed using the most current version of the Nutrition Data System for Research software (NDSR).
|
12 months
|
|
Infant diet at 1 month
Time Frame: 1 month
|
24-hour diet recalls will be conducted for one week day and one weekend day.
Mothers will be interviewed to report on their infant's food intake.
Dietary intake will be collected and analyzed using the most current version of the Nutrition Data System for Research software (NDSR).
|
1 month
|
|
Infant diet at 6 months
Time Frame: 6 months
|
24-hour diet recalls will be conducted for one week day and one weekend day.
Mothers will be interviewed to report on their infant's food intake.
Dietary intake will be collected and analyzed using the most current version of the Nutrition Data System for Research software (NDSR).
|
6 months
|
|
Infant diet at 12 months
Time Frame: 12 months
|
24-hour diet recalls will be conducted for one week day and one weekend day.
Mothers will be interviewed to report on their infant's food intake.
Dietary intake will be collected and analyzed using the most current version of the Nutrition Data System for Research software (NDSR).
|
12 months
|
|
Infant feeding score assessed by Infant Feeding Questionnaire at 1 month
Time Frame: 1 month
|
Infant feeding score will be assessed using the Baughcum Infant Feeding Questionnaire.
Questions are scored using the following scale: 1-5; never, rarely, sometimes, often, always.
Average scores will be used to determine the following constructs: concern about the child undereating or becoming underweight; concern about infant's hunger; awareness of infant's cues; concern about the infant becoming overweight or overeating; feeding the infant on schedule; using food to calm the infant; social interaction during feeding.
|
1 month
|
|
Infant feeding style score assessed by Infant Feeding Style Questionnaire at 1 month
Time Frame: 1 month
|
Infant feeding style score will be assessed using the Thompson Infant Feeding Style Questionnaire.
Questions are scored using the following scale: 1-5; disagree, slightly disagree, neutral, slightly agree, agree.
Average scores will be used to determine the following constructs: laissez-faire; pressuring; restrictive; responsive; and indulgent.
|
1 month
|
|
Infant behavior score assessed by Infant Behavior Questionnaire at 1 month
Time Frame: 1 month
|
Infant behavior score will be assessed using the Rothbart Infant Behavior Questionnaire.
Questions are scored using the following scale: 1-7; never, very rarely, less than half the time, about half the time, more than half the time, almost always, always.
Composite scores will be used to determine the following constructs: surgency/extroversion; negative affectivity; and orienting/regulation.
|
1 month
|
|
Infant eating behavior score assessed by Baby Eating Behavior Questionnaire at 1 month
Time Frame: 1 month
|
Infant eating behavior score will be assessed using the Llewellyn Baby Eating Behavior Questionnaire.
Questions are scored using the following scale: 1-5; never, rarely, sometimes, often, always.
Average scores will be used to determine the following constructs: food responsiveness; satiety responsiveness; slowness in eating; enjoyment of food; and general appetite.
|
1 month
|
|
Breast milk composition at 1 month
Time Frame: 1 month
|
Breast milk will be collected from mothers at least 11⁄2 hours since the last feeding and while the mother has fasted at least 1 hour.
Samples will be analyzed for glucose, fructose, galactose, lactose and sucrose by mass spectrometry.
Samples will be available for analysis of insulin, leptin, and energy content.
|
1 month
|
|
Breast milk composition at 6 months
Time Frame: 6 months
|
Breast milk will be collected from mothers at least 11⁄2 hours since the last feeding and while the mother has fasted at least 1 hour.
Samples will be analyzed for glucose, fructose, galactose, lactose and sucrose by mass spectrometry.
Samples will be available for analysis of insulin, leptin, and energy content.
|
6 months
|
|
Breast milk composition at 12 months
Time Frame: 12 months
|
Breast milk will be collected from mothers at least 11⁄2 hours since the last feeding and while the mother has fasted at least 1 hour.
Samples will be analyzed for glucose, fructose, galactose, lactose and sucrose by mass spectrometry.
Samples will be available for analysis of insulin, leptin, and energy content.
|
12 months
|
|
Infant Magnetic Resonance Imaging (MRI) brain scan at 1 month
Time Frame: 1 month
|
Infant brain will be scanned using Magnetic Resonance Imaging (MRI) to measure structure and function.
|
1 month
|
|
Infant gut microbiome at 1 Month
Time Frame: 1 month
|
Stool samples will be collected in OmniGUT gene kits and aliquoted to be stored at -80oC.
Gut microbes will be analyzed using 16S sequencing.
|
1 month
|
|
Infant gut microbiome at 6 Months
Time Frame: 6 months
|
Stool samples will be collected in OmniGUT gene kits and aliquoted to be stored at -80oC.
Gut microbes will be analyzed using 16S sequencing.
|
6 months
|
|
Infant gut microbiome at 12 Months
Time Frame: 12 months
|
Stool samples will be collected in OmniGUT gene kits and aliquoted to be stored at -80oC.
Gut microbes will be analyzed using 16S sequencing.
|
12 months
|
|
Maternal gut microbiome at 1 month
Time Frame: 1 month
|
Stool samples will be collected in OmniGUT gene kits and aliquoted to be stored at -80oC.
Gut microbes will be analyzed using 16S sequencing.
|
1 month
|
|
Infant Diet and Behavior Questionnaire at 1 month
Time Frame: 1 month
|
Participants will report when they stopped breastfeeding/introduced formula or solid foods.
|
1 month
|
|
Infant Diet and Behavior Questionnaire at 6 months
Time Frame: 6 months
|
Participants will report when they stopped breastfeeding/introduced formula or solid foods.
|
6 months
|
|
Infant Diet and Behavior Questionnaire at 12 months
Time Frame: 12 months
|
Participants will report when they stopped breastfeeding/introduced formula or solid foods.
|
12 months
|
|
CDC Infant Feeding Practices Survey II at 1 month
Time Frame: 1 month
|
Participants will answer questions about their and their infant's diet.
|
1 month
|
|
CDC Infant Feeding Practices Survey II at 6 months
Time Frame: 6 months
|
Participants will answer questions about their and their infant's diet.
|
6 months
|
|
CDC Infant Feeding Practices Survey II at 12 months
Time Frame: 12 months
|
Participants will answer questions about their and their infant's diet.
|
12 months
|
|
Maternal Beverage Recall at Pregnancy visit 1
Time Frame: 24-28 weeks' gestation
|
Participants will report the beverages they have consumed over the past week.
This data will be used to assess nutritional intake based on beverages.
|
24-28 weeks' gestation
|
|
Maternal Beverage Recall at Pregnancy visit 2
Time Frame: ~35 weeks' gestation
|
Participants will report the beverages they have consumed over the past week.
This data will be used to assess nutritional intake based on beverages.
|
~35 weeks' gestation
|
|
Maternal Beverage Recall at 1 month
Time Frame: 1 month
|
Participants will report the beverages they have consumed over the past week.
This data will be used to assess nutritional intake based on beverages.
|
1 month
|
|
Maternal Beverage Recall at 6 months
Time Frame: 6 months
|
Participants will report the beverages they have consumed over the past week.
This data will be used to assess nutritional intake based on beverages.
|
6 months
|
|
Maternal Beverage Recall at 12 months
Time Frame: 12 months
|
Participants will report the beverages they have consumed over the past week.
This data will be used to assess nutritional intake based on beverages.
|
12 months
|
|
Infant Beverage Recall at 1 month
Time Frame: 1 month
|
Mother's will report the beverages their infant has consumed over the past week.
This data will be used to assess nutritional intake based on beverages.
|
1 month
|
|
Infant Beverage Recall at 6 months
Time Frame: 6 months
|
Mother's will report the beverages their infant has consumed over the past week.
This data will be used to assess nutritional intake based on beverages.
|
6 months
|
|
Infant Beverage Recall at 12 months
Time Frame: 12 months
|
Mother's will report the beverages their infant has consumed over the past week.
This data will be used to assess nutritional intake based on beverages.
|
12 months
|
|
Perinatal Anxiety Screening Scale (PASS) at Pregnancy visit 1
Time Frame: 24-28 weeks' gestation
|
Participants will answer questions regarding their stress levels during and after pregnancy.
Minimum = 0; maximum = 93.
Higher scores represent worse outcomes.
|
24-28 weeks' gestation
|
|
Perinatal Anxiety Screening Scale (PASS) at Pregnancy visit 2
Time Frame: ~35 weeks' gestation
|
Participants will answer questions regarding their stress levels during and after pregnancy.
Minimum = 0; maximum = 93.
Higher scores represent worse outcomes.
|
~35 weeks' gestation
|
|
Perinatal Anxiety Screening Scale (PASS) at 1 month
Time Frame: 1 month
|
Participants will answer questions regarding their stress levels during and after pregnancy.
Minimum = 0; maximum = 93.
Higher scores represent worse outcomes.
|
1 month
|
|
Perinatal Anxiety Screening Scale (PASS) at 6 months
Time Frame: 6 months
|
Participants will answer questions regarding their stress levels during and after pregnancy.
Minimum = 0; maximum = 93.
Higher scores represent worse outcomes.
|
6 months
|
|
Perinatal Anxiety Screening Scale (PASS) at 12 months
Time Frame: 12 months
|
Participants will answer questions regarding their stress levels during and after pregnancy.
Minimum = 0; maximum = 93.
Higher scores represent worse outcomes.
|
12 months
|
|
Edinburgh Postnatal Depression Scale (EPDS) at Pregnancy visit 1
Time Frame: 24-28 weeks' gestation
|
Participants will answer questions regarding their feelings and mood.
Minimum = 0, maximum = 30.
Higher scores represent worse outcomes.
|
24-28 weeks' gestation
|
|
Edinburgh Postnatal Depression Scale (EPDS) at Pregnancy visit 2
Time Frame: ~35 weeks' gestation
|
Participants will answer questions regarding their feelings and mood.
Minimum = 0, maximum = 30.
Higher scores represent worse outcomes.
|
~35 weeks' gestation
|
|
Edinburgh Postnatal Depression Scale (EPDS) at 1 month
Time Frame: 1 month
|
Participants will answer questions regarding their feelings and mood.
Minimum = 0, maximum = 30.
Higher scores represent worse outcomes.
|
1 month
|
|
Edinburgh Postnatal Depression Scale (EPDS) at 6 months
Time Frame: 6 months
|
Participants will answer questions regarding their feelings and mood.
Minimum = 0, maximum = 30.
Higher scores represent worse outcomes.
|
6 months
|
|
Edinburgh Postnatal Depression Scale (EPDS) at 12 months
Time Frame: 12 months
|
Participants will answer questions regarding their feelings and mood.
Minimum = 0, maximum = 30.
Higher scores represent worse outcomes.
|
12 months
|
|
Pregnancy Physical Activity Questionnaire at Pregnancy visit 1
Time Frame: 24-28 weeks' gestation
|
Participants will answer questions about their physical activity levels over the past week.
Minimum: 0 (none), maximum: 5 (3 or more hours per day).
Higher scores represent better outcomes.
|
24-28 weeks' gestation
|
|
Pregnancy Physical Activity Questionnaire at Pregnancy visit 2
Time Frame: ~35 weeks' gestation
|
Participants will answer questions about their physical activity levels over the past week.
Minimum: 0 (none), maximum: 5 (3 or more hours per day).
Higher scores represent better outcomes.
|
~35 weeks' gestation
|
|
Pregnancy Physical Activity Questionnaire at 1 month
Time Frame: 1 month
|
Participants will answer questions about their physical activity levels over the past week.
Minimum: 0 (none), maximum: 5 (3 or more hours per day).
Higher scores represent better outcomes.
|
1 month
|
|
Pregnancy Physical Activity Questionnaire at 6 months
Time Frame: 6 months
|
Participants will answer questions about their physical activity levels over the past week.
Minimum: 0 (none), maximum: 5 (3 or more hours per day).
Higher scores represent better outcomes.
|
6 months
|
|
Pregnancy Physical Activity Questionnaire at 12 months
Time Frame: 12 months
|
Participants will answer questions about their physical activity levels over the past week.
Minimum: 0 (none), maximum: 5 (3 or more hours per day).
Higher scores represent better outcomes.
|
12 months
|
|
Pittsburgh Sleep Quality Index (PSQI) at Pregnancy visit 1
Time Frame: 24-28 weeks' gestation
|
Participants will answer questions about their sleeping habits over the past week.
|
24-28 weeks' gestation
|
|
Pittsburgh Sleep Quality Index (PSQI) at Pregnancy visit 2
Time Frame: ~35 weeks' gestation
|
Participants will answer questions about their sleeping habits over the past week.
|
~35 weeks' gestation
|
|
Pittsburgh Sleep Quality Index (PSQI) at 1 month
Time Frame: 1 month
|
Participants will answer questions about their sleeping habits over the past week.
|
1 month
|
|
Pittsburgh Sleep Quality Index (PSQI) at 6 months
Time Frame: 6 months
|
Participants will answer questions about their sleeping habits over the past week.
|
6 months
|
|
Pittsburgh Sleep Quality Index (PSQI) at 12 months
Time Frame: 12 months
|
Participants will answer questions about their sleeping habits over the past week.
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Michael I Goran, University of Southern California; Children's Hospital Los Angeles
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 18, 2019
Primary Completion (Actual)
July 1, 2020
Study Completion (Actual)
July 1, 2020
Study Registration Dates
First Submitted
December 8, 2020
First Submitted That Met QC Criteria
December 14, 2020
First Posted (Actual)
December 17, 2020
Study Record Updates
Last Update Posted (Actual)
December 6, 2024
Last Update Submitted That Met QC Criteria
December 3, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CHLA-18-00455
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States